Business StandardANAVEX® Life Sciences Corp.Jul 30, 20151 min readNew drug may boost brain power in Alzheimer’s patientsClick here to read article
Anavex Life Sciences to Present Oral Blarcamesine Data at the 18th Clinical Trials on Alzheimer’s Disease (CTAD) Conference
Anavex Life Sciences Reports Fiscal 2025 Fourth Quarter Financial Results and Provides Business Update
